Lifestyle Modification is a structured change in everyday behaviors that influence health. In cardiology, it is a prevention and long-term management strategy rather than a single test or procedure. It commonly targets diet, physical activity, tobacco exposure, sleep, and stress-related behaviors. It is used across primary prevention, secondary prevention after cardiovascular events, and chronic disease care.

Preventive Cardiology is the branch of cardiology focused on reducing the risk of cardiovascular disease before events occur and preventing recurrence after an event. It is a clinical domain centered on risk assessment, risk factor modification, and long-term disease management. It is commonly applied in outpatient clinics, primary care–cardiology co-management, and post-hospital follow-up after cardiovascular events. Its scope spans lifestyle counseling, pharmacotherapy, and selective use of diagnostic testing to guide prevention strategies.

Cardiac Screening is the systematic evaluation of cardiovascular risk or silent (asymptomatic) heart disease. It sits in the diagnostic and preventive domain of cardiology, using history, examination, and selected tests. It is commonly used in primary care, pre-participation sports clearance, occupational health, and preoperative assessment. Its goal is to identify people who may benefit from closer evaluation or risk-reduction strategies.

Hypercoagulability is a state in which blood has an increased tendency to form clots. It is a pathophysiologic concept used across cardiology, hematology, and perioperative medicine. Clinically, it helps explain venous thromboembolism (VTE) and some arterial thrombotic events. It is commonly discussed during evaluation of thrombosis, stroke, myocardial infarction, and device-related clot risk.

Family History is a structured record of health conditions in biologic relatives. In clinical medicine, it is a diagnostic and risk stratification tool rather than an anatomy finding or a therapy. It is commonly used in cardiology to assess inherited risk for atherosclerotic cardiovascular disease, cardiomyopathies, arrhythmias, and congenital heart disease. It also guides decisions about screening, preventive counseling, and when to consider genetic evaluation.

Sedentary Lifestyle describes a pattern of waking behavior with prolonged sitting or reclining and low energy expenditure. It is primarily a preventive cardiology and cardiovascular risk concept rather than an anatomic structure or procedure. It is commonly discussed in outpatient medicine, inpatient discharge planning, and cardiac rehabilitation. It is assessed through clinical history, functional capacity estimates, and sometimes wearable activity data.

Metabolic Syndrome is a clinical diagnosis defined by a cluster of cardiometabolic risk factors that tend to occur together. It is a risk stratification concept used in internal medicine, cardiology, and primary care. It commonly includes central adiposity, elevated blood pressure, dysglycemia, and atherogenic dyslipidemia. It is used to identify patients at higher risk for atherosclerotic cardiovascular disease (ASCVD) and type 2 diabetes mellitus.

Obesity is a chronic disease characterized by excess body fat that can impair health. It is commonly defined and staged using anthropometric measures such as body mass index (BMI). Obesity is discussed across preventive medicine, endocrinology, cardiology, and perioperative care. It is frequently used in risk assessment for atherosclerotic cardiovascular disease and heart failure.

Diabetes Mellitus is a group of metabolic diseases characterized by chronic hyperglycemia (elevated blood glucose). It is a disease entity that affects multiple organ systems through vascular, inflammatory, and metabolic mechanisms. It is commonly discussed in primary care, endocrinology, cardiology, nephrology, and perioperative medicine. It is frequently identified using laboratory diagnostics such as fasting plasma glucose and hemoglobin A1c (HbA1c).

Smoking is the inhalation of smoke from burning tobacco or other plant material. In clinical medicine, Smoking is a modifiable exposure that affects cardiovascular, pulmonary, and systemic disease risk. It is most commonly documented during history-taking, risk assessment, perioperative planning, and preventive care discussions. In cardiology, it is frequently referenced when evaluating atherosclerotic cardiovascular disease and thrombotic events.